The US Food and Drug Administration (FDA) has cleared Covalon's SurgiClear antimicrobial silicone adhesive film dressing.
SurgiClear antimicrobial silicone dressing is designed to cover and protect wound sites and wound closure devices, as well as secure other primary dressings to a patient’s skin.
Prvious studies have shown that SurgiClear is up to ten times less painful on removal than other film dressings that use acrylic adhesives.
Other studies have shown that the use over a 14-day period of silicone similar to SurgiClear prevents keloid and hypertrophic scarring following surgical procedures.
Covalon chief executive officer Brian Pedlar said the FDA clearance of SurgiClear, the clearance of its sister product IV Clear a few months ago, and clinical feedback received to date provides the company with all of the validity necessary to license and sell both products.
"Every year in the United States, over 48 million in-patient procedures result in wounds that could benefit from SurgiClear’s antimicrobial silicone technology," Pedlar added.